Skip to content
PaperFren

Host–pathogen

How open is the Listeria pan-genome?

Kuenne C, Billion A, Mraheil MA, et al. · BMC genomics · 2013

Open access · cc by · source: Europe PMC

Eleven new genomes spanning serotypes show a stable but open pan-genome with nine hypervariable hotspots dominated by mobile elements.

Study at a glance

Design
Computational / modelling — Extended L. monocytogenes complete-genome set covering all serotypes for pan-genome analysis
N
N=16 · 16 completely sequenced chromosomes (extended by 11 strains in this work)
Population
Listeria monocytogenes genomes across serotypes
Outcome
Pan-genome stability and accessory-gene hotspot dynamics

Structured fields used in claim comparison tables when every cited study has a complete layer.

Key findings

The pan-genome is highly stable but not closed; accessory genes concentrate in hypervariable hotspots with mobile genetic elements as major accessory components.

Methodology

Extended L. monocytogenes genome sets by 11 strains covering all serotypes and reassessed pan-genome structure.

Limitations

Gene presence/absence aids diagnostics/phylogenetics but does not alone prove each virulence phenotype.

How this study connects

Role on claims

Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.

  • SupportsHost–pathogenconcept

    The pan-genome is highly stable but not closed; accessory genes concentrate in hypervariable hotspots with mobile genetic elements as major accessory components.

    Evidence for the claim as stated.

  • SupportsPhylogenetic Analysismethod

    Aspergillus clade genomics and a Listeria pan-genome reassessment use trees and gene-content matrices together. Aspergillus genomes were ~29–36 Mb with 9,113–13,553 genes, about 20% Aspergillaceae-specific, and section Nigri averaged ~1,800 unique genes. Extending L. monocytogenes by 11 strains covering all serotypes showed a highly stable but not closed pan-genome, with accessory genes in hypervariable hotspots and mobile elements as major accessory components.

    Evidence for the claim as stated.

  • SupportsPhylogenetic Analysismethod

    These papers do not build the same kind of tree. HSP90 and MYB papers classify gene families; the immune-gene paper scans orthologs for repeated positive selection (~14% selected in all tests); Aspergillus and Listeria papers mix clade phylogeny with pan-genome gene content; turtle and Medicago papers are organismal genomes whose phylogeny is background for physiology or breeding. A student who treats every 'phylogenetic analysis' hit as a species tree will misread the result.

    Evidence for the claim as stated.

  • SupportsPhylogenetic Analysismethod

    What 'accessory' or 'lineage-specific' genes imply is itself unsettled. Listeria accessory genes concentrate in hotspots with mobile elements and aid diagnostics, but presence/absence does not prove each virulence phenotype. Aspergillus section Nigri's ~1,800 unique genes are not experimentally validated one by one. Immune-gene sharing of selection between birds and mammals can be convergence or ancient pressure.

    Evidence for the claim as stated.

  • Many papers in the CRISPR index mention CRISPR or Cas proteins in passing while the actual experiment is something else (APEX2 proximity labelling, pan-genome presence/absence, ChIP-seq of histone acylations, scRNA-seq of endoderm). Those hits show why a body-count lexicon over-recruits; they are not additional editing results.

    Evidence for the claim as stated.

  • The strongest tension is naming. The 2007 array paper and the Listeria pan-genome treat CRISPR as a genomic feature of bacteria; the Cas13a and dCas9 papers treat CRISPR–Cas as a laboratory tool. Both usages are historically connected, but a finding about repeat RNA folding does not license a claim about editing a human promoter, and a CasIP result does not catalogue environmental CRISPR diversity.

    Evidence for the claim as stated.

Open questions

Tensions this paper is part of

From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.

  • Scope difference — different assays, populations, or outcomes

    These papers do not build the same kind of tree. HSP90 and MYB papers classify gene families; the immune-gene paper scans orthologs for repeated positive selection (~14% selected in all tests); Aspergillus and Listeria papers mix clade phylogeny with pan-genome gene content; turtle and Medicago papers are organismal genomes whose phylogeny is background for physiology or breeding. A student who treats every 'phylogenetic analysis' hit as a species tree will misread the result.

  • Scope difference — different assays, populations, or outcomes

    What 'accessory' or 'lineage-specific' genes imply is itself unsettled. Listeria accessory genes concentrate in hotspots with mobile elements and aid diagnostics, but presence/absence does not prove each virulence phenotype. Aspergillus section Nigri's ~1,800 unique genes are not experimentally validated one by one. Immune-gene sharing of selection between birds and mammals can be convergence or ancient pressure.

  • Scope difference — different assays, populations, or outcomes

    The strongest tension is naming. The 2007 array paper and the Listeria pan-genome treat CRISPR as a genomic feature of bacteria; the Cas13a and dCas9 papers treat CRISPR–Cas as a laboratory tool. Both usages are historically connected, but a finding about repeat RNA folding does not license a claim about editing a human promoter, and a CasIP result does not catalogue environmental CRISPR diversity.

Related papers in this topic

Same topic cluster — not a recommendation engine.